Please ensure Javascript is enabled for purposes of website accessibility

LabCorp and Quest to Offer Coronavirus Tests

By Joe Tenebruso - Mar 7, 2020 at 4:05PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The clinical lab giants want to help meet the urgent need for COVID-19 testing.

Laboratory Corporation of America (LH 0.26%) and Quest Diagnostics (DGX -0.01%) recently announced the launch of testing services for COVID-19, the disease caused by the novel coronavirus. LabCorp's test has been available since Thursday, while Quest will begin testing on Monday, March 9. 

The announcements come at a time when multiple doctors have complained about their inability to get their patients tested for COVID-19. Thanks to the size of their laboratory networks, Quest and LabCorp are expected to bring what many doctors say is vital to containment efforts: effective testing done at scale.

"As COVID-19 continues to spread in the U.S., having high-quality, reliable, scalable laboratory tests available is a critically important part of the response," LabCorp's chief scientific officer, Marcia Eisenberg, said in a press release. "Identifying people who are infected is necessary to make sure that patients receive the appropriate care, to better manage the use of healthcare resources, and to help contain the spread of the virus." 

A person wearing gloves performing a test in a laboratory.

LabCorp and Quest will help doctors test their patients for COVID-19. Image source: Getty Images.

It should be noted that neither LabCorp nor Quest will collect specimens on suspected COVID-19 cases. Instead, specimens are to be collected at healthcare facilities, such as hospitals and physician offices, and sent to Quest or LabCorp using standard procedures. LabCorp says test results will be made available in as little as 3 days. 

Health officials have praised LabCorp's and Quest's decision to join the COVID-19 testing efforts. "These large platforms are great national assets and their contribution at a critical juncture is going to make a difference," former FDA Commissioner Scott Gottlieb said. 

Joe Tenebruso has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Quest Diagnostics Incorporated Stock Quote
Quest Diagnostics Incorporated
DGX
$140.55 (-0.01%) $0.02
Laboratory Corporation of America Holdings Stock Quote
Laboratory Corporation of America Holdings
LH
$259.42 (0.26%) $0.68

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
400%
 
S&P 500 Returns
128%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/14/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.